ArticleTaiwan journal of ophthalmology
Choroidal vascularity index changes in proliferative and nonproliferative macular telangiectasia type 2.
Article in Taiwan journal of ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study aimed to evaluate the choroidal vascularity index (CVI) in patients with nonproliferative and proliferative macular telangiectasia type 2 (MacTel-2) compared to healthy controls, assess the impact of ellipsoid zone (EZ) disruption on CVI, and determine whether CVI measurements vary with different binarization areas. MATERIALS AND
methodsCVIs from MacTel-2 eyes were compared to those of healthy controls. MacTel-2 eyes were categorized as proliferative or nonproliferative and further subdivided by the presence or absence of EZ disruption. CVI was measured in three regions: 1500 µm, 4000 µm, and the total macular choroidal area (TCA). Statistical analyses included paired samples
resultsThis study included 90 eyes each from MacTel-2 patients and healthy controls. CVIs did not significantly differ between eyes with and without EZ disruption in either MacTel-2 group (
conclusionEZ disruption does not affect CVI. CVIs were similar in nonproliferative and proliferative MacTel-2, both lower than in healthy eyes. CVI also remained consistent across different binarization areas, confirming its reliability regardless of area size.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.